tirzepatide fda update confirms shortage is still over, gives compounders a grace period FDA Approves Tirzepatide (Zepbound) as

Was I tracking food accurately

Is the use of GLP-1's for weight loss behind the trend

Imatinib, bestatin, roflumilast, palacaparib, thalidomide/pomalidomide and semaglutide outperform the current standard of care by reducing mortality and/or neurological deficits in mice via suppression of neuroinflammation

But the real first scientific breakthrough that happened was in the early 70s

But certain symptoms need prompt attention: Severe muscle pain, tenderness, or weakness that limits daily activities Dark or tea colored urine (this can be a sign of rhabdomyolysis, a rare but serious condition involving muscle breakdown) Swelling, redness, or warmth in a specific joint Body aches accompanied by fever or chills Symptoms that worsen with each dose increase and do not improve between doses Rhabdomyolysis is extremely rare, but it has been reported in at least one case linked to tirzepatide use

Scientific insight and access equity must advance together for the next era of autoimmune care